IP Library Granted Patent US 8,298,797
Granted Patent B2
US 8,298,797 · App. 12/825,523 · Granted Oct 30, 2012

Δ-9 elongases and their use in making polyunsaturated fatty acids

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,298,797
App. No.
12/825,523
Granted
Oct 30, 2012
Kind
B2
Abstract

The present invention relates to Δ9 elongases, which have the ability to convert linoleic acid (LA; 18:2 ω-6) to eicosadienoic acid (EDA; 20:2 ω-6) and/or α-linolenic acid (ALA; 18:3 ω-3) to eicosatrienoic acid (ETrA; 20:3 ω-3). Isolated nucleic acid fragments and recombinant constructs comprising such fragments encoding Δ9 elongases along with a method of making long-chain polyunsaturated fatty acids (PUFAs) using these Δ9 elongases in oleaginous yeast are disclosed.

Claims (15)

1. A method for the production of at least one polyunsaturated fatty acid selected from the group consisting of eicosadienoic acid and eicosatrienoic acid comprising:

a) providing a transformed microbial host cell comprising:

(i) a recombinant nucleotide molecule encoding a polypeptide having delta-9 elongase activity, wherein the polypeptide has at least 90% amino acid identity, based on the Clustal V method of alignment, when compared to the amino acid sequence as set forth in SEQ ID NO:13 or SEQ ID NO:14; and

(ii) a source of a substrate polyunsaturated fatty acid selected from the group consisting of linoleic acid and alpha-linolenic acid;

b) growing the transformed microbial host cell of step (a) under conditions wherein linoleic acid is converted to eicosadienoic acid and alpha-linolenic acid is converted to eicosatrienoic acid; and

c) optionally recovering the eicosadienoic acid and/or eicosatrienoic acid of step (b).

2. The method of claim 1 , wherein the transformed microbial host cell is a Yarrowia , said polypeptide has the full-length amino acid sequence set forth in SEQ ID No. 27, and the recombinant nucleotide molecule comprises at least 98 codons which are optimized for expression in Yarrowia.

3. The method according to claim 1 , wherein:

a) the recombinant nucleotide molecule has the full-length nucleic acid sequence selected from the group consisting of SEQ ID NO:11, SEQ ID NO:12 and SEQ ID NO:26; and

b) the host cell is Yarrowia lipolytica.

4. The method according to claim 1 wherein the transformed microbial host cell is selected from the group consisting of yeast, algae, bacteria, euglenoids, stramenopiles and fungi.

5. The method according to claim 4 wherein the transformed microbial host cell is a fungus of the genus Mortierella.

6. The method according to claim 4 wherein the transformed microbial host cell is a stramenopile selected from the group consisting of: Thraustochytrium and Schizochytrium.

7. The method according to claim 4 wherein the transformed microbial host cell is an oleaginous yeast.

8. The method according to claim 7 wherein the transformed microbial host cell is an oleaginous yeast selected from the group consisting of: Yarrowia, Candida, Rhodotorula, Rhodosporidium, Cryptococcus, Trichosporon and Lipomyces.

Assignments (2)
CORRECTIVE ASSIGNMENT TO CORRECT THE DESIGNATION OF ASSIGNEE AS A DELAWARE CORPORATION TO A DELAWARE LIMITED LIABILITY COMPANY PREVIOUSLY RECORDED ON REEL 049880 FRAME 0001. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Aug 28, 2019
From: E. I. DU PONT DE NEMOURS AND COMPANY
To: DUPONT US HOLDING, LLC
Reel/Frame 051502/0610 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 26, 2019
From: E. I. DU PONT DE NEMOURS AND COMPANY
To: DUPONT US HOLDING, LLC
Reel/Frame 049880/0001 →